Patent details
EP3218061
Title:
CARMUSTINE PHARMACEUTICAL COMPOSITION
Basic Information
- Publication number:
- EP3218061
- PCT Application Number:
- US2015060052
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP158598615
- PCT Publication Number:
- WO2016077406
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CARMUSTINE PHARMACEUTICAL COMPOSITION
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE DE CARMUSTINE
- German Title of Invention:
- PHARMAZEUTISCHE CARMUSTIN-ZUSAMMENSETZUNG
- SPC Number:
-
Dates
- Filing date:
- 11/11/2015
- Grant date:
- 29/06/2022
- EP Publication Date:
- 20/09/2017
- PCT Publication Date:
- 19/05/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/06/2022
- EP B1 Publication Date:
- 29/06/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/11/2022
- Expiration date:
- 11/11/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/06/2022
-
-
- Name:
- Navinta III Inc
- Address:
- 1003 Clint Moore Road, Boca Raton, FL 33487, United States (US)
Inventor
- Name:
- PATEL, Mahendra R.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201462080091 P
- Priority Date:
- 14/11/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201514936227
- Priority Date:
- 09/11/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/19;
A61K 47/10;
A61P 35/00;
A61K 31/17;
A61K 31/175;
Publication
European Patent Bulletin
- Issue number:
- 202226
- Publication date:
- 29/06/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |